Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 2 days agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over...
Restoring sight is possible now with optogenetics
Washington Post· 5 days agoAs a child, Max Hodak learned to develop film in a darkroom with his late grandfather who was almost blind. Hodak’s grandfather had retinitis pigmentosa,...
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoOcugen (OCGN) is expected to provide updates regarding the developmental program of its lead...
UN labor agency report warns of rising threat of excess heat, climate change on world's workers
Associated Press via Yahoo News· 6 days agoThe U.N. labor organization warned Monday that over 70% of the world's workforce is likely to be...
Oculis (NASDAQ:OCS) Price Target Cut to $28.00
ETF DAILY NEWS· 2 days agoOculis (NASDAQ:OCS – Get Free Report) had its price target dropped by research analysts at HC Wainwright from $29.00 to $28.00 in a research note issued to investors on Wednesday, Benzinga reports ...
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...
Morningstar· 6 days agoCognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual ...
How a migrant farmworker built generational wealth, penny by penny
LA Times via Yahoo Finance· 2 days agoMy grandfather kept ledgers logging every day he worked in the U.S. The dry entries — "18 boxes of...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 4 days agoResearch analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating ...
Ocugen (NASDAQ:OCGN) Given New $5.00 Price Target at Chardan Capital
ETF DAILY NEWS· 6 days agoOcugen (NASDAQ:OCGN – Get Free Report) had its price objective increased by stock analysts at Chardan Capital from $4.00 to $5.00 in a research report issued on Monday, Benzinga reports. Chardan ...
Eye Health 101: Things You Should Be Doing Every Day to Take Care of Your Vision
CNET· 5 days agoVision loss is a major problem that interrupts daily life. The US Centers for Disease Control and Prevention estimates that 93 million adults in the US are at high risk of vision loss. Although ...
